Gossamer Bio Announces Participation in Upcoming Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Nov 26, 2019--
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that members of the management team will participate in the following investor conferences:
- Piper Jaffray 31 st Annual Healthcare Conference on Tuesday, December 3 at 1:30 p.m. ET in New York
- Evercore ISI 2 nd Annual HealthCONx Conference on Wednesday, December 4 at 11:20 a.m. ET in Boston
A live webcast of the presentations will be available on the “Events and Presentations” page in the “Investors” section of the company’s website at https://ir.gossamerbio.com. A replay of the webcast will be archived on the company’s website for 90 days following the presentation.
About Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191126005147/en/
CONTACT: For Investors:
email@example.com For Media:
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH CLINICAL TRIALS
SOURCE: Gossamer Bio, Inc.
Copyright Business Wire 2019.
PUB: 11/26/2019 07:00 AM/DISC: 11/26/2019 07:01 AM